Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines External Web Site Icon P. Nicolisi et al, JAMA Oncology, February 8, 2019

Specific PHGKB|Cancer|PHGKB

Prostate Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Feb 08, 2019

---

• Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines  
  P. Nicolisi et al, JAMA Oncology, February 8, 2019
• Cancer prevention and screening: the next step in the era of precision medicine.  
  Loomans-Kropp Holli A et al. NPJ precision oncology 2019 33
• Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men.  
  Rogers Charles R et al. American journal of preventive medicine 2018 Nov 55(5S1) S103-S111
• Genomics of Prostate Cancer: What Nurses Need to Know.  
  McReynolds Katharine M et al. Seminars in oncology nursing 2019 Jan
• Metastatic Prostate Cancer: Effects of Genetic Testing on Care.  
  Connors Laurie M et al. Clinical journal of oncology nursing 2019 Feb 23(1) 32-35
• epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer  
  E. O'Reilly et al, JCO Precision Oncology, January 2019
• Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.  
  Li F et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jan
• What Is the Effectiveness of Patient Decision Aids for Cancer-Related Decisions? A Systematic Review Subanalysis.  
  McAlpine Kristen et al. JCO clinical cancer informatics 2018 Dec (2) 1-13
• What do men understand about lifetime risk following genetic testing? The effect of context and numeracy.  
  Rolison Jonathan J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2012 Jul 31(4) 530-3
• BRCAness and prostate cancer: diagnostic and therapeutic considerations.  
  Dhawan Mallika et al. Prostate cancer and prostatic diseases 2018 21(4) 488-498